Health

In mid-stage trials, two newer targeted therapies have shown meaningful activity against HER2-positive biliary tract cancers in pretreated patients with advanced disease. According to Shubham Pant, MD, of the MD Anderson Cancer Center in Houston, cohort 1 of the global HERIZON-BTC-01 study, which included 80 treatment-refractory patients, showed that 41.3% responded to zanidatamab, an investigational
A small case-control study has revealed that an index of gliosis was associated with persistent neurocognitive symptoms after mild or moderate SARS-CoV-2 infection. Researchers found that PET measures of translocator protein total distribution volume (TSPO VT), a marker of gliosis, were elevated in people with ongoing cognitive and depressive symptoms after COVID-19. In comparison to
The United States Food and Drug Administration (FDA) has granted full approval for nirmatrelvir-ritonavir (Paxlovid), an antiviral medication, for the treatment of mild to moderate COVID-19 in adult outpatients who are at risk of severe disease. The approval follows an endorsement from the FDA’s Antimicrobial Drugs Advisory Committee and is a critical component of President
U.S. News & World Report has released its latest “Best Medical Schools” rankings for the academic year 2023-2024. The rankings have undergone several changes in methodology, including an increase in the weightage given to outcome measures and a decrease in the emphasis on reputation and selectivity. The rankings have also been affected by some high-profile
A 95-year-old female farmer from rural Japan presented at the emergency department with abdominal symptoms that had persisted for months. She denied drinking alcohol, but was taking prednisolone and lansoprazole for bullous pemphigoid diagnosed 8 months prior. Her symptoms included loss of appetite, intermittent abdominal bloating, diarrhea, abdominal pain, and shortness of breath. Upon examination,
The Consumer Financial Protection Bureau (CFPB) has issued a warning for patients against costly medical credit cards and loans. These products can cause patients to pay significantly more than they otherwise would have. The Problem with Medical Financing Products Medical financing products, such as medical credit cards, medical installment loans, health savings accounts, and flexible